Jianfeng Group Pro 2015-016 Jianfeng Group Stock Abnormal Volatility Announcement
Release time:
2020-08-05
Bond Abbreviation: 13 Peak 01 Bond Code: 122227
Bond Abbreviation: 13 Peak 02 Bond Code: 122344
Zhejiang Jianfeng Group Co., Ltd. Stock Trading Abnormal Fluctuation Announcement
The board of directors and all directors of the company guarantee that the content of this announcement does not contain any false records, misleading statements or major omissions, and the content Individual and joint responsibility for the authenticity, accuracy and completeness of the content.
Important Content Reminder: Zhejiang Jianfeng Group Co., Ltd. (hereinafter referred to as "the company" or "the company") stock closed for three consecutive trading days on July 2, 3, and 6, 2015. The cumulative deviation of price decline exceeds 20%, which belongs to abnormal stock trading fluctuations.
Details of Abnormal Fluctuations in 1. Stock Trading The daily closing price of the Company's shares fell by more than 20% for three consecutive trading days on July 2, 3 and 6, 2015. According to the relevant provisions of the Trading Rules of the Shanghai Stock Exchange, it belongs to abnormal fluctuations in stock trading.
Relevant Information Concerned and Verified by the 2. Company 1. After self-examination by the Company, the Company's current production and operation activities are normal; There are no major issues that should be disclosed but not disclosed that affect abnormal stock price fluctuations. 2. After consulting with the company's controlling shareholders and actual controllers, it is confirmed that the company, the company's controlling shareholders and actual controllers do not have major information that should be disclosed but not disclosed, including but not limited to major asset restructuring, share issuance, and listing of the company. Major issues such as company acquisition, debt restructuring, business restructuring, asset divestiture and asset injection.
Statement 3. whether there is material information that should be disclosed but not disclosed The board of directors of the company confirms that according to the Shanghai Stock Exchange Stock Listing Rules and other relevant regulations, the company does not have any matters that should be disclosed but not disclosed Or planning, negotiation, intention, agreement, etc. related to the matter, the board of directors has not been informed that the company has information that should be disclosed but not disclosed in accordance with the "Shanghai Stock Exchange Stock Listing Rules" and other relevant regulations, which has a greater impact on the trading prices of the company's stocks and derivatives.
Risk Tips deemed necessary by 4. listed companies The company's designated information disclosure website is the Shanghai Stock Exchange website (www.sse.com.cn), and the designated information disclosure newspapers are Shanghai Securities News, "China Securities Journal", all publicly disclosed information of the company is subject to the announcements published on the above designated websites and newspapers. Investors are kindly requested to invest rationally and pay attention to investment risks.
This is to announce
Zhejiang Jianfeng Group Co., Ltd.
Board of Directors
July 7, 2015
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page